The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure

被引:43
作者
Reyes, AJ [1 ]
机构
[1] Inst Cardiovasc Theory, Montevideo 11700, Uruguay
关键词
antioxidant capacity; diuretics; heart failure; oxidative stress; uric acid;
D O I
10.1016/j.ejheart.2004.03.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with mild-moderate chronic heart failure (CHF) often have raised levels of serum uric acid (UA). This is due, amongst other factors, to reduced UA excretion by the kidneys, which is partly explained by restriction of sodium intake and treatment with diuretics. The decline in renal function that parallels worsening cardiac function also contributes to elevated serum UA in patients with advanced CHF. However, UA production also appears to be augmented in CHF. Because UA scavenges various reactive oxygen species, diuretic-induced elevations in serum UA could be beneficial in patients with CHF. This concept is supported by the superior performance of antiftypertensive therapy with diuretics in preventing heart failure. The present hypothesis may be tested by examining the effects of add-on treatment with a thiazide-type diuretic on morbidity and mortality, or surrogate variables, in asymptomatic patients with left ventricular dysfunction but without fluid retention. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:461 / 467
页数:7
相关论文
共 115 条
  • [1] Serum uric acid and cardiovascular events in successfully treated hypertensive patients
    Alderman, MH
    Cohen, H
    Madhavan, S
    Kivlighn, S
    [J]. HYPERTENSION, 1999, 34 (01) : 144 - 150
  • [2] *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
  • [3] Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
    Anker, SD
    Doehner, W
    Rauchhaus, M
    Sharma, R
    Francis, D
    Knosalla, C
    Davos, CH
    Cicoira, M
    Shamim, W
    Kemp, M
    Segal, R
    Osterziel, KJ
    Leyva, F
    Hetzer, R
    Ponikowski, P
    Coats, AJS
    [J]. CIRCULATION, 2003, 107 (15) : 1991 - 1997
  • [4] [Anonymous], PROG PHARM CLIN PHAR
  • [5] [Anonymous], J HYPERTENSION S
  • [6] Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
    Berry, CE
    Hare, JM
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03): : 589 - 606
  • [7] Predictors of prognosis in patients with stable mild to moderate heart failure
    Bettencourt, P
    Ferreira, A
    Dias, P
    Pimenta, J
    Frioes, F
    Martins, L
    Cerqueira-Gomes, M
    [J]. JOURNAL OF CARDIAC FAILURE, 2000, 6 (04) : 306 - 313
  • [8] BURNIER M, 1994, J HYPERTENS, V12, pS7
  • [9] Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy
    Cappola, TP
    Kass, DA
    Nelson, GS
    Berger, RD
    Rosas, GO
    Kobeissi, ZA
    Marbán, E
    Hare, JM
    [J]. CIRCULATION, 2001, 104 (20) : 2407 - 2411
  • [10] URIC-ACID METABOLISM AND TUBULAR SODIUM HANDLING - RESULTS FROM A POPULATION-BASED STUDY
    CAPPUCCIO, FP
    STRAZZULLO, P
    FARINARO, E
    TREVISAN, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (03): : 354 - 359